A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer

Clinical significance of PDEF factor expression and its relation to androgen receptor in ER- breast cancer

(2018) Lu Cao et al.   HISTOPATHOLOGY

Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment

(2018) Hitisha K. Patel et al.   PHARMACOLOGY & THERAPEUTICS

Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer

(2018) Rasmus Siersbæk et al.   GENES & DEVELOPMENT

AR–PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer

(2018) Lu Cao et al.   Molecular Cancer

Estrogen alpha receptor antagonists for the treatment of breast cancer: a review

(2018) Deepika Sharma et al.   Chemistry Central Journal

Androgen Receptor Function and Androgen Receptor–Targeted Therapies in Breast Cancer

(2017) Miho Kono et al.   JAMA Oncology

Effect of selective estrogen receptor modulators on metabolic homeostasis

(2016) Beibei Xu et al.   BIOCHIMIE

The selective estrogen receptor modulators in breast cancer prevention

(2016) Fangxuan Li et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Androgen receptor signaling pathways as a target for breast cancer treatment

(2016) Elisabetta Pietri et al.   ENDOCRINE-RELATED CANCER

Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet

(2016) Ernest U. Ekpo et al.   INTEGRATIVE CANCER THERAPIES

Signatures of prostate-derived Ets factor (PDEF) in cancer

(2016) Nitin Mahajan   TUMOR BIOLOGY

Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status

(2016) He-Sheng Jiang et al.   Oncotarget

Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer

(2014) V Craig Jordan   ENDOCRINE-RELATED CANCER

Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review)

(2014) RUBÍ VIEDMA-RODRÍGUEZ et al.   ONCOLOGY REPORTS

PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells

(2013) Gilles Buchwalter et al.   CANCER CELL

Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women

(2011) R. Hu et al.   CLINICAL CANCER RESEARCH

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1

(2011) Jessica L L Robinson et al.   EMBO JOURNAL

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

(2011) Laura C Collins et al.   MODERN PATHOLOGY

A refined molecular taxonomy of breast cancer

(2011) M Guedj et al.   ONCOGENE

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

(2010) Isabella Castellano et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of androgen receptors in primary breast cancer

(2009) S. Park et al.   ANNALS OF ONCOLOGY

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

(2009) Francesca De Amicis et al.   BREAST CANCER RESEARCH AND TREATMENT

Androgen Receptor Inhibits Estrogen Receptor-  Activity and Is Prognostic in Breast Cancer

(2009) A. A. Peters et al.   CANCER RESEARCH